The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
Self-citationThe Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Self-citationThe Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Nielsen, T. O., Hsu, F. D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., Hernandez-Boussard, T., Livasy, C., Cowan, D., Dressler, L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0220 · Cited by 2,663
Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy
Rouzier, R., Perou, C. M., Symmans, W. F., Ibrahim, N., Cristofanilli, M., Anderson, K., Hess, K. R., Stec, J., Ayers, M., Wagner, P., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2421 · Cited by 1,891
Melanoma biology and new targeted therapy
Gray-Schopfer, V., Wellbrock, C., & Marais, R. (2007) · Nature · doi:10.1038/nature05661 · Cited by 1,371 · cited 1×
“In fact, the consistent histological and intrinsic breast cancer classification of the basal-type cell lines strongly suggests that a melanoma-like gene mutation profile (that includes mutations in p16, RB1 and RAS pathway genes [42]) is characteristic for basal-type breast cancers.”
BackgroundPromoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Esteller, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.564 · Cited by 1,233 · cited 1×
“Promoter hypermethylation was determined for BRCA1, E-cadherin, p16, p14ARF and RB1, by azacytidine assays and/or methylation-specific PCR ([23]; Hollestelle et al.”
MethodAn integrative genomic and proteomic analysis of pik3ca, pten, and akt mutations in breast cancer.
Stemke-Hale, K., Gonzalez-Angulo, A. M., Lluch, A., Neve, R. M., Kuo, W.-L., Davies, M., Carey, M., Hu, Z., Guan, Y., Sahin, A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6854 · Cited by 1,054
Saal, L. H., Holm, K., Maurer, M., Memeo, L., Su, T., Wang, X., Yu, J. S., Malmström, P.-O., Mansukhani, M., Enoksson, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472-can-04-3913 · Cited by 875
Subtypes of Breast Cancer Show Preferential Site of Relapse
Smid, M., Wang, Y., Zhang, Y., Sieuwerts, A. M., Yu, J., Klijn, J. G. M., Foekens, J. A., & Martens, J. W. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5644 · Cited by 813
Self-citationMutations of the human E-cadherin (CDH1) gene
Berx, G., Becker, K.-F., Höfler, H., & van Roy, F. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:4<226::aid-humu2>3.0.co;2-d · Cited by 607
Divorcing ARF and p53: an unsettled case
Sherr, C. J. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1954 · Cited by 595
Expression of luminal and basal cytokeratins in human breast carcinoma
Abd El‐Rehim, D. M., Pinder, S. E., Paish, C. E., Bell, J., Blamey, R., Robertson, J. F., Nicholson, R. I., & Ellis, I. O. (2004) · The Journal of Pathology · doi:10.1002/path.1559 · Cited by 594
Basal-like breast cancer and the BRCA1 phenotype
Turner, N. C., & Reis-Filho, J. S. (2006) · Oncogene · doi:10.1038/sj.onc.1209876 · Cited by 478
Ten Genes for Inherited Breast Cancer
Walsh, T., & King, M.-C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.010 · Cited by 477
Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., & Johnson, M. D. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9392-8 · Cited by 374
Saal, L. H., Gruvberger-Saal, S. K., Persson, C., Lövgren, K., Jumppanen, M., Staaf, J., Jönsson, G., Pires, M. M., Maurer, M., Holm, K., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.39 · Cited by 355
Self-citationBørresen-Dale, A.-L. (2003) · Human Mutation · doi:10.1002/humu.10174 · Cited by 354
Fulford, L. G., Easton, D. F., Reis‐Filho, J. S., Sofronis, A., Gillett, C. E., Lakhani, S. R., & Hanby, A. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02453.x · Cited by 352
Phosphatidylinositol-3-OH Kinase or RAS Pathway Mutations in Human Breast Cancer Cell Lines
Hollestelle, A., Elstrodt, F., Nagel, J. H. A., Kallemeijn, W. W., & Schutte, M. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0263 · Cited by 320
Self-citationBRCA1 Mutation Analysis of 41 Human Breast Cancer Cell Lines Reveals Three New Deleterious Mutants
Elstrodt, F., Hollestelle, A., Nagel, J. H. A., Gorin, M., Wasielewski, M., van den Ouweland, A., Merajver, S. D., Ethier, S. P., & Schutte, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2853 · Cited by 305
Self-citationCharacterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier.
Tomlinson, G. E., Chen, T. T., Stastny, V., Virmani, A. K., Spillman, M. A., Tonk, V. S., Blum, J. L., Schneider, N. R., Wistuba, I. I., Shay, J. W., et al. (1998) · PubMed · Cited by 294
Barnes, D. M., & Gillett, C. E. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006103831990 · Cited by 243
Mutations in p53 as potential molecular markers for human breast cancer.
Runnebaum, I. B., Nagarajan, M., Bowman, M., Soto, D., & Sukumar, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10657 · Cited by 222
MDA-MB-435 and M14 Cell Lines: Identical but not M14 Melanoma?
Chambers, A. F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1528 · Cited by 218
Jaffee, E. M., Hruban, R. H., Canto, M., & Kern, S. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00093-4 · Cited by 215
Gauthier, M. L., Berman, H. K., Miller, C., Kozakeiwicz, K., Chew, K., Moore, D., Rabban, J., Chen, Y. Y., Kerlikowske, K., & Tlsty, T. D. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.017 · Cited by 214
Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
Teng, D. H. ‐., Perry, W. L., Hogan, J. K., Baumgard, M., Bell, R. N., Berry, S., Davis, T., Frank, D., Frye, C., Hattier, T., et al. (1997) · PubMed · Cited by 193
Oda, K., Okada, J., Timmerman, L., Rodriguez-Viciana, P., Stokoe, D., Shoji, K., Taketani, Y., Kuramoto, H., Knight, Z. A., Shokat, K. M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0755 · Cited by 189
Rakha, E. A., El‐Sayed, M. E., Green, A. R., Paish, E. C., Lee, A. H. S., & Ellis, I. O. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02638.x · Cited by 169
Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.
van de Wetering, M., Barker, N., Harkes, I. C., van der Heyden, M. A. G., Dijk, N. J., Hollestelle, A., Klijn, J. G. M., Clevers, H. C., & Schutte, M. E. M. (2001) · PubMed · Cited by 163
Self-citationMechanisms of inactivation of E-cadherin in breast cancer cell lines.
Hiraguri, S., Godfrey, T. E., Nakamura, H., Graff, J. R., Collins, C. C., Shayesteh, L., Doggett, N. A., Johnson, K. J., Wheelock, M. J., Herman, J. G., et al. (1998) · PubMed · Cited by 149
Basal carcinoma of the breast revisited: an old entity with new interpretations
Korsching, E., Jeffrey, S. S., Meinerz, W., Decker, T. W., Boecker, W., & Buerger, H. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2008.055475 · Cited by 119
Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines
Wasielewski, M., Elstrodt, F., Klijn, J. G. M., Berns, E. M. J. J., & Schutte, M. E. M. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9186-z · Cited by 112
Self-citationSieuwerts, A. M., Gelder, M. E. M., Timmermans, M. A. M., Trapman-Jansen, A., Garcia, R. R., Arnold, M., Goedheer, A. J. W., Portengen, H., Klijn, J. G. M., & Foekens, J. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0560 · Cited by 84
Self-citation(1976) · PubMed · Cited by 73
TP53 mutations in familial breast cancer: Functional aspects
Gasco, M., Yuluğ, I. G., & Crook, T. (2003) · Human Mutation · doi:10.1002/humu.10173 · Cited by 71
Mutation rate of MAP2K4/MKK4 in breast carcinoma
Su, G. H., Song, J. J., Repasky, E. A., Schutte, M. E. M., & Kern, S. E. (2001) · Human Mutation · doi:10.1002/humu.9002 · Cited by 64
Self-citationConcin, N., Zeillinger, C., Castillo‐Tong, D. C., Stimpfl, M., König, M., Printz, D., Stonek, F., Schneeberger, C., Hefler, L., Kainz, C., et al. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1023351717408 · Cited by 49
Prosperi, M., Dupré, G., Lidereau, R., & Goubin, G. (1990) · Cancer Letters · doi:10.1016/0304-3835(90)90053-z · Cited by 18
Foekens, J. A., Wang, Y., Martens, J. W. M., Berns, E. M. J. J., & Klijn, J. G. M. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.03.003 · Cited by 17
Self-citationDeleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines
Wasielewski, M., Hanifi-Moghaddam, P., Hollestelle, A., Merajver, S. D., van den Ouweland, A., Klijn, J. G. M., Ethier, S. P., & Schutte, M. E. M. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9942-3 · Cited by 11
Self-citation
Cited by
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Choosing the right cell line for breast cancer research
Holliday, D. L., & Speirs, V. (2011) · Breast Cancer Research · doi:10.1186/bcr2889 · Cited by 1,541
Deconstructing the molecular portraits of breast cancer
Prat, A., & Perou, C. M. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2010.11.003 · Cited by 1,343
Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping
Dai, X., Cheng, H., Bai, Z., & Li, J. (2017) · Journal of Cancer · doi:10.7150/jca.18457 · Cited by 1,100
Tan, T. Z., Miow, Q. H., Miki, Y., Noda, T., Mori, S., Huang, R. Y., & Thiery, J. P. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404208 · Cited by 792
Metadata
- Authors
- Hollestelle, A., Nagel, J. H. A., Smid, M., Lam, S., Elstrodt, F., Wasielewski, M., Ng, S. S., French, P. J., Peeters, J. K., Rozendaal, M. J., Riaz, M., Koopman, D. G., ten Hagen, T. L. M., de Leeuw, B. H. C. G. M., Zwarthoff, E. C., Teunisse, A., van der Spek, P. J., Klijn, J. G. M., Dinjens, W. N. M., Ethier, S. P., Clevers, H., Jochemsen, A. G., den Bakker, M. A., Foekens, J. A., Martens, J. W. M., & Schutte, M.
- Venue
- Breast Cancer Research and Treatment
- Published
- 2009-07-11
- Volume
- 121
- Issue
- 1
- Pages
- 53-64
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W2157423592
- Cited by
- 301
- References
- 48
- FWCI
- 6.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.